Page last updated: 2024-08-21

quinazolines and Intestinal Polyps

quinazolines has been researched along with Intestinal Polyps in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alferez, D; Goodlad, RA; Mandir, N; Poulsom, R; Pyrah, IT; Ryan, AJ; Smith, NR; Watkins, AJ; Wedge, SR; Wilkinson, RW	1
Buchanan, FG; DuBois, RN; Holla, V; Katkuri, S; Matta, P	1

Other Studies

2 other study(ies) available for quinazolines and Intestinal Polyps

Article	Year
Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer. Carcinogenesis, 2006, Volume: 27, Issue:10 Topics: Adenoma; Animals; Female; Genes, APC; Intestinal Neoplasms; Intestinal Polyps; Male; Mice; Mice, Inbred C57BL; Quinazolines; RNA, Messenger; Signal Transduction; Splenomegaly; Vascular Endothelial Growth Factor Receptor-2	2006
Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer. Cancer research, 2007, Oct-01, Volume: 67, Issue:19 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; ErbB Receptors; Erlotinib Hydrochloride; Humans; Immunohistochemistry; Intestinal Polyps; Intestine, Small; Mice; Mice, Inbred C57BL; Oligonucleotide Array Sequence Analysis; Prostaglandins; Pyrazoles; Quinazolines; Sulfonamides; Xenograft Model Antitumor Assays	2007

Article

Year

Inhibiting vascular endothelial growth factor receptor-2 signaling reduces tumor burden in the ApcMin/+ mouse model of early intestinal cancer.

Carcinogenesis, 2006, Volume: 27, Issue:10

Topics: Adenoma; Animals; Female; Genes, APC; Intestinal Neoplasms; Intestinal Polyps; Male; Mice; Mice, Inbred C57BL; Quinazolines; RNA, Messenger; Signal Transduction; Splenomegaly; Vascular Endothelial Growth Factor Receptor-2

2006

Targeting cyclooxygenase-2 and the epidermal growth factor receptor for the prevention and treatment of intestinal cancer.

Cancer research, 2007, Oct-01, Volume: 67, Issue:19

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; ErbB Receptors; Erlotinib Hydrochloride; Humans; Immunohistochemistry; Intestinal Polyps; Intestine, Small; Mice; Mice, Inbred C57BL; Oligonucleotide Array Sequence Analysis; Prostaglandins; Pyrazoles; Quinazolines; Sulfonamides; Xenograft Model Antitumor Assays

2007